UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Breast cancer research and treatment, 2012-02, Vol.132 (1), p.215-223

2012

Volltextzugriff (PDF)

Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-26

2018

Volltextzugriff (PDF)

Abstract PD3-04: Analysis of ERBB2 (HER2) amplification by ctDNA in a phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib in women with metastatic disease with initially diagnosed HER2+ breast cancer: NSABP FB-10

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-04-PD3-04

2019

Volltextzugriff (PDF)

Abstract P6-20-01: METRIC: A randomized international phase 2b study of the antibody-drug conjugate (ADC) glembatumumab vedotin (GV) in gpNMB-overexpressing, metastatic, triple-negative breast cancer (mTNBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-20-01

2019

Volltextzugriff (PDF)

A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer

Value in health, 2016-05, Vol.19 (3), p.A169-A170

2016

Volltextzugriff (PDF)

PCN202 - A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer

Value in health, 2016-05, Vol.19 (3), p.A169-A170

2016

Volltextzugriff (PDF)

Abstract P6-09-03: Improved clinical outcomes associated with statin use during adjuvant chemotherapy in patients with HER2+ non-metastatic breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-09-03

2013

Volltextzugriff (PDF)

Abstract P1-04-16: Multi-center experience with CELLSEARCH® circulating tumor cell kit on patients with metastatic breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-04-16

2013

Volltextzugriff (PDF)

PCN93 - Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

Value in health, 2016-05, Vol.19 (3), p.A150-A150

2016

Volltextzugriff (PDF)

Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

Value in health, 2016-05, Vol.19 (3), p.A150-A150

2016

Volltextzugriff (PDF)

COMPARATIVE COST-EFFECTIVENESS OF EARLY-STAGE BREAST CANCER TREATMENTS IN THE ELDERLY

Value in health, 2017-05, Vol.20 (5), p.A9

2017

Volltextzugriff (PDF)

Abstract P4-13-24: Impact of genomic medicine on clinical decision making in patients with advanced breast cancer at two academic medical centers

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-13-24

2016

Volltextzugriff (PDF)

Abstract P6-09-02: Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ non-metastatic breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-09-02

2013

Volltextzugriff (PDF)

Abstract P1-12-03: Low-dose capecitabine monotherapy in HER-2 negative metastatic breast cancer: a retrospective study

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P1-P1-12-03

2012

Volltextzugriff (PDF)

Daily injections of the glutathione disulfide mimetic NOV-002 ameliorates hematologic toxicities from neoadjuvant chemotherapy in breast cancer patients enrolled in the NEO-NOVO trial, and significantly increases circulating dendritic cells

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2141

2009

Volltextzugriff (PDF)

Drift Kinetic Equation Solver for Grid (DKEsG)

IEEE transactions on plasma science, 2010-09, Vol.38 (9), p.2093-2101

2010

Volltextzugriff (PDF)

Abstract P1-11-05: Phase 2 Study of Neoadjuvant Treatment with Cellular Redox Modulator NOV-002 in Combination with Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) in Patients with Stage II-III HER-2 (-) Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-11-05

2010

Volltextzugriff (PDF)

Acute respiratory distress syndrome after rituximab infusion

International journal of hematology, 2005-11, Vol.82 (4), p.324-326

2005

Volltextzugriff (PDF)

Vulvar Langerhans cell histiocytosis: a case report and review of the literature

Gynecologic oncology, 2003-10, Vol.91 (1), p.241-246

2003

Volltextzugriff (PDF)

Langerhans cell histiocytosis of the female genital tract: A literature review

International journal of gynecological cancer, 2003-05, Vol.13 (3), p.381-388

2003

Volltextzugriff (PDF)

The department without walls. Acceptability, cost, and utilization of interactive video technology

Archives of family medicine, 1997-05, Vol.6 (3), p.273-278

1997

Volltextzugriff (PDF)

A framework for modelling the biomechanical behaviour of the human liver during breathing in real time using machine learning

Expert systems with applications, 2017-04, Vol.71, p.342-357

2017

Volltextzugriff (PDF)

Effect of the arachidonic acid/vitamin E interaction on the immune response of juvenile Atlantic salmon (Salmo salar) challenged against Piscirickettsia salmonis

Aquaculture nutrition, 2017-08, Vol.23 (4), p.710-720

2017

Volltextzugriff (PDF)

El valor de la sarcopenia en la prevención de la discapacidad

Medicina clínica, 2019, Vol.153 (6), p.243-244

2019

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(44)
Biological And Medical Sciences
(30)
Fundamental And Applied Biological Sciences. Psychology
(19)
Humans
(19)
Food Industries
(18)
Food Science & Technology
(18)
Fish And Seafood Industries
(16)
Female
(14)
Male
(12)
Adult
(11)
Medical Sciences
(11)
Physical Sciences
(11)
Middle Aged
(9)
Chemistry
(8)
Chemistry, Applied
(8)
Hematology
(7)
Internal Medicine
(7)
Adolescent
(6)
Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Abstract P5-21-26: T-DM1 activity in metastatic HER2-positive breast cancer patients who have received prior trastuzumab and pertuzumab: NSABP B-005

Abstract PD3-04: Analysis of ERBB2 (HER2) amplification by ctDNA in a phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib in women with metastatic disease with initially diagnosed HER2+ breast cancer: NSABP FB-10

Abstract P6-20-01: METRIC: A randomized international phase 2b study of the antibody-drug conjugate (ADC) glembatumumab vedotin (GV) in gpNMB-overexpressing, metastatic, triple-negative breast cancer (mTNBC)

A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer

PCN202 - A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer

Abstract P6-09-03: Improved clinical outcomes associated with statin use during adjuvant chemotherapy in patients with HER2+ non-metastatic breast cancer

Abstract P1-04-16: Multi-center experience with CELLSEARCH® circulating tumor cell kit on patients with metastatic breast cancer

PCN93 - Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer

COMPARATIVE COST-EFFECTIVENESS OF EARLY-STAGE BREAST CANCER TREATMENTS IN THE ELDERLY

Abstract P4-13-24: Impact of genomic medicine on clinical decision making in patients with advanced breast cancer at two academic medical centers

Abstract P6-09-02: Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ non-metastatic breast cancer

Abstract P1-12-03: Low-dose capecitabine monotherapy in HER-2 negative metastatic breast cancer: a retrospective study

Daily injections of the glutathione disulfide mimetic NOV-002 ameliorates hematologic toxicities from neoadjuvant chemotherapy in breast cancer patients enrolled in the NEO-NOVO trial, and significantly increases circulating dendritic cells

Drift Kinetic Equation Solver for Grid (DKEsG)

Abstract P1-11-05: Phase 2 Study of Neoadjuvant Treatment with Cellular Redox Modulator NOV-002 in Combination with Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) in Patients with Stage II-III HER-2 (-) Breast Cancer

Acute respiratory distress syndrome after rituximab infusion

Vulvar Langerhans cell histiocytosis: a case report and review of the literature

The natural history of breast carcinoma in patients with ≥ 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy : A multiinstitutional retrospective study

Langerhans cell histiocytosis of the female genital tract: A literature review

The department without walls. Acceptability, cost, and utilization of interactive video technology

A framework for modelling the biomechanical behaviour of the human liver during breathing in real time using machine learning

Effect of the arachidonic acid/vitamin E interaction on the immune response of juvenile Atlantic salmon (Salmo salar) challenged against Piscirickettsia salmonis

El valor de la sarcopenia en la prevención de la discapacidad

Suchergebnisse filtern